Ginkgo bioworks announces participation in the 41st annual j.p. morgan healthcare conference

Boston , jan. 4, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, announced today that co-founder and ceo jason kelly is scheduled to present at the 41st annual j.p. morgan healthcare conference on wednesday, january 11, 2023 at 11:15 a.m.

DNA Ratings Summary

DNA Quant Ranking